Molecular markers in acute myeloid leukaemia. - Wikidata - awgldk - TriplyDB

Molecular markers in acute myeloid leukaemia.

Molecular markers in acute myeloid leukaemia.

http://www.wikidata.org/entity/Q38026007

about

Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory Analysis Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs Acute myelogenous leukemia at Baylor Charles A. Sammons Cancer Center, 2010 to 2012: retrospective analysis of molecular genetic evaluation.Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.Modeling normal and malignant human hematopoiesis in vivo through newborn NSG xenotransplantation.Retinoid receptor signaling and autophagy in acute promyelocytic leukemia.Minimal residual disease testing in hematologic malignancies and solid cancer.Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.Evaluation of prognostic factors in patients with therapy-related acute myeloid leukemia.Mitochondrial cytochrome c oxidase subunit II variations predict adverse prognosis in cytogenetically normal acute myeloid leukaemia.

P2860

Q26776393-1026406A-8C05-4DFA-97B1-47789B1CAB85 Q26797245-AC77746D-311B-4EC6-9463-96C429FF6037 Q26991440-C2DC9BEF-91C2-4D5B-BABA-EBCAA6C1F600 Q34632079-4848A595-9E9C-4853-BFF0-FF4FBFBC7A3D Q34655572-07632C24-CECF-485C-B838-A0EBE604C3E3 Q38109541-F85FE5C3-2E02-4AF7-BC73-AD1611C0F23F Q38164593-48514721-C050-4EF1-923D-048436726107 Q38201532-69E100C6-8DA8-4C78-8F92-88BE0DF19D87 Q38220970-E1F2280F-9315-40D6-8EFE-93105663D8A8 Q38253011-E9CFE93E-C44F-4AE5-9A8A-D96A50314FF5 Q42196299-9BE67DEA-0C76-4716-A77F-7318DE2D896A Q50858174-BA9C908C-0C9F-4933-A370-98520A3D91E6

P2860

Molecular markers in acute myeloid leukaemia.

http://www.wikidata.org/entity/Q38026007

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Molecular markers in acute myeloid leukaemia.

@en

type

label

Molecular markers in acute myeloid leukaemia.

@en

prefLabel

Molecular markers in acute myeloid leukaemia.

@en

P1433

Q38026007-088DF827-67E9-4D5B-9EA3-BB8066BF489F

P1476

Q38026007-32815985-376D-4B79-9DD7-CD121A6E25CB

P2093

Q38026007-493EFD53-71D2-4727-9875-C3F4EFE4692A

Q38026007-73399865-B0F6-406A-B9F7-1329D1C5E2B7

P2860

Q38026007-013156D3-ACE6-4D2E-99BF-27E90B60082D

Q38026007-0707C4F1-0C0E-4E1F-B373-B2E66B601151

Q38026007-073B5D70-CB72-4BBA-8C16-F0C8B8C8BCB8

Q38026007-08BD2FC2-67F5-4E89-B6F9-4F81F04AD711

Q38026007-0E834060-1B15-4A82-A7DC-9274006C46E1

Q38026007-19F6290A-DD82-4435-ABF6-31292C4A78DE

Q38026007-1B06994C-016F-4717-9613-EE87EF998C9F

Q38026007-1C5E9B83-BCD2-43E1-9940-537446224458

Q38026007-21BCAAB5-C6EB-457E-8D6E-ED6F6AC7D4E0

Q38026007-220A4DB3-8A28-48CE-88DB-B8D5BCD5BF63

P2888

Q38026007-81EDEA95-BD94-4A10-B1F7-10418D07C91C

P304

Q38026007-EF0774A9-502B-4DF7-976E-CB1089E0EF75

P31

Q38026007-DC5C05D9-760F-44A3-B3A6-92E7355A3F80

P356

Q38026007-D1119DA6-1433-4CE6-8C32-BAD10B08D2D3

P433

Q38026007-7763B461-9B54-40FF-A4A9-7EABF19C82DD

P478

Q38026007-ECFFDBEB-8929-4AD5-9DFF-1723F1289F7A

P577

Q38026007-D2BCCE7D-9507-4986-8296-5E0FDA7E151C

P5875

Q38026007-78634D77-A417-40C4-AEA4-637BE8033ED5

P6179

Q38026007-CCA758D7-C988-4D51-A122-D32CC25134CF

P698

Q38026007-FC46DD39-9769-451C-A7ED-A8D92B13F145

P921

Q38026007-C2DB2A98-5C9E-4379-9D5D-0763704103B3

P356

S12185-012-1123-9

P1433

International Journal of Hematology

P1476

Molecular markers in acute myeloid leukaemia.

@en

P2093

Andrea Kühnl

http://www.w3.org/2001/XMLSchema#string

David Grimwade

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

Recurring mutations found by sequencing an acute myeloid leukemia genome

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

DNMT3A Mutations in Acute Myeloid Leukemia

The prognostic and functional role of microRNAs in acute myeloid leukemia

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

P2888

s12185-012-1123-9

P304

153-163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-012-1123-9

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229082519

http://www.w3.org/2001/XMLSchema#string

P6179

1026657314

http://www.w3.org/2001/XMLSchema#string

P698

22791509

http://www.w3.org/2001/XMLSchema#string

P921